156 related articles for article (PubMed ID: 12756607)
1. Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report.
Umemoto S; Itagaki K; Kimura M; Itoh S; Tanaka M; Haraguchi M; Matsuzaki M
Heart Vessels; 2003 May; 18(2):100-2. PubMed ID: 12756607
[TBL] [Abstract][Full Text] [Related]
2. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of suplatast tosilate on eosinophil migration].
Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
Yoshihara S; Fukuda H; Arisaka O
Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
6. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
Watanabe M; Yamaguchi K; Yamanishi T; Kamai T; Yoshida K
Hinyokika Kiyo; 2009 Nov; 55(11):715-9. PubMed ID: 19946192
[TBL] [Abstract][Full Text] [Related]
7. Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
Satoh T; Sasaki G; Wu MH; Yokozeki H; Katayama I; Nishioka K
Clin Immunol; 2003 Sep; 108(3):257-62. PubMed ID: 14499249
[TBL] [Abstract][Full Text] [Related]
8. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
[TBL] [Abstract][Full Text] [Related]
9. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
10. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
11. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats.
Shimizu S; Hattori R; Majima Y; Shimizu T
Ann Otol Rhinol Laryngol; 2009 Jan; 118(1):67-72. PubMed ID: 19244966
[TBL] [Abstract][Full Text] [Related]
12. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma.
Shioya T; Satake M; Sano M; Kagaya M; Watanabe A; Sato K; Ito T; Ito N; Sasaki M; Miura M
Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601
[TBL] [Abstract][Full Text] [Related]
13. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma.
Yokomura K; Suda T; Matsuda H; Hashizume H; Asada K; Suzuki K; Chida K
J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
15. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
[TBL] [Abstract][Full Text] [Related]
16. Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects.
Agrawal DK; Cheng G; Kim MJ; Kiniwa M
Clin Exp Allergy; 2008 Feb; 38(2):305-12. PubMed ID: 18028459
[TBL] [Abstract][Full Text] [Related]
17. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effect of suplatast tosilate on mild asthma.
Sano Y; Miyamoto T; Makino S
Chest; 1997 Sep; 112(3):862-3. PubMed ID: 9315837
[No Abstract] [Full Text] [Related]
19. Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies.
Furukido K; Takeno S; Ueda T; Hirakawa K; Yajin K
Am J Rhinol; 2002; 16(6):329-36. PubMed ID: 12512908
[TBL] [Abstract][Full Text] [Related]
20. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]